Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Learn why index funds are a practical choice for long-term investing, emphasizing diversification, low fees, and a hands-off approach for steady growth.
28,023 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Poland’s wild stock market is capturing renewed interest as diversification in Europe. The iShares Poland ETF offers ...
Fidelity’s Active Large Growth ETF threads a narrow but meaningful edge over passive peers as AI-enabled demand fuels...
Oil prices rise for the fifth straight week as U.S. military moves in the Middle East escalate. Traders weigh supply ...
Unanimity in board votes can mask risk. A fresh comparison to avalanche safety training shows why dissent matters for...
META sits at a pivotal moment. With AI-enabled engagement, ad momentum, and new monetization paths, analysts wonder i...
AI is reshaping software earnings. This article dives into Jensen Huang's view, two stock ideas, and practical steps ...
Geopolitical risk is a powerful driver for defense spending. This guide explains how iran fallout: israel needs could...
Grayscale is moving to turn staking rewards from its Ethereum and Solana staking ETFs into cash payouts on a quarterl...
The ethereum trust (etha) lost roughly half its value in 2026 while a strong payroll print reinforced a risk-off mood...
Micron ralled dramatically in May as memory chips rode AI and data-center demand. This deep dive explains what fueled...
The wheaton precious metals stock faced a sharp June pullback as gold and silver paused. This article breaks down the...